跳至主要内容
临床试验/JPRN-UMIN000043061
JPRN-UMIN000043061招募中未知

STRIDE Study to evaluate the effect of Tofogliflozin on VRH In T2DM using ECG - STRIDE

Sapporo Medical University0 个研究点目标入组 100 人开始时间: 2021年1月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of hypersensitivity to tofogliflozin 2) Severe ketosis, diabetic coma or precoma 3) Ssevere infections, before and after surgery, and with serious trauma 4) Taking tofogliflozin in the past 5) Atrial fibrillation 6) With artificial pacemaker, or implantable cardioverter-defibrillator 7) Chronic kidney disease (CKD) stage 4 and 5 8) Pregnancy, lactating women, patients with the intention of becoming pregnant 9) Patients judged inappropriate

研究者

相似试验